Publisher: DelveInsight
Category: Prescription Drugs

Prescription Drugs market research reports by DelveInsight

(641 reports matching your criteria)
    • Viralym-M Emerging Drug Insight and Market Forecast – 2032

      Viralym-M Emerging Drug Insight and Market Forecast – 2032 “Viralym-M Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Viralym-M for Hemorrhagic Cystitis in the 7MM. A detailed picture of the Viralym-M for Hemorrhagic Cystitis in the 7MM, i.e., United St ... Read More

    • PENTHROX Drug Insight and Market Forecast – 2032

      PENTHROX Drug Insight and Market Forecast – 2032 “PENTHROX Drug Insight and Market Forecast – 2032” report provides comprehensive insights about PENTHROX for Postoperative Pain in the 7MM. A detailed picture of the PENTHROX for Postoperative Pain in the 7MM, i.e., United States, EU5 (Germany, France ... Read More

    • XOLAIR Drug Insight and Market Forecast – 2032

      XOLAIR Drug Insight and Market Forecast – 2032 “XOLAIR Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XOLAIR for Nasal Polyposis in the 7MM. A detailed picture of the XOLAIR for Nasal Polyposis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain ... Read More

    • NUCALA Drug Insight and Market Forecast – 2032

      NUCALA Drug Insight and Market Forecast – 2032 “NUCALA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about NUCALA for Nasal Polyposis in the 7MM. A detailed picture of the NUCALA for Nasal Polyposis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain ... Read More

    • EPI-589 Emerging Drug Insight and Market Forecast – 2032

      EPI-589 Emerging Drug Insight and Market Forecast – 2032 “EPI-589 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EPI-589 for Amyotrophic Lateral Sclerosis in the 7MM. A detailed picture of the EPI-589 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., ... Read More

    • BNC210, Emerging Drug Insight and Market Forecast – 2032

      BNC210, Emerging Drug Insight and Market Forecast – 2032 “BNC210, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about BNC210 for Post-traumatic Stress Disorder in seven major markets. A detailed picture of the BNC210 for Post-traumatic Stress Disorder in 7M ... Read More

    • FLT190, Emerging Drug Insight and Market Forecast – 2032

      FLT190, Emerging Drug Insight and Market Forecast – 2032 “FLT190, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about FLT190 for Fabry Disease in the 7MM. A detailed picture of the FLT190 for Fabry Disease in the 7MM, i.e., United States, EU5 (Germany, Fran ... Read More

    • REPLAGAL, Drug Insight and Market Forecast – 2032

      REPLAGAL, Drug Insight and Market Forecast – 2032 “REPLAGAL, Drug Insight and Market Forecast – 2032” report provides comprehensive insights about REPLAGAL for Fabry Disease in the 7MM. A detailed picture of the REPLAGAL for Fabry Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, ... Read More

    • XOLAIR Emerging Drug Insight and Market Forecast – 2032

      XOLAIR Emerging Drug Insight and Market Forecast – 2032 “XOLAIR Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about XOLAIR for Food Allergy in the 7MM. A detailed picture of the XOLAIR for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, ... Read More

    • CA002 Emerging Drug Insight and Market Forecast – 2032

      CA002 Emerging Drug Insight and Market Forecast – 2032 “CA002 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CA002 for Food Allergy in the 7MM. A detailed picture of the CA002 for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, Ital ... Read More

    • ST-920, Emerging Drug Insight and Market Forecast – 2032

      ST-920, Emerging Drug Insight and Market Forecast – 2032 “ST-920, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ST-920 for Fabry Disease in the 7MM. A detailed picture of the ST-920 for Fabry Disease in the 7MM, i.e., United States, EU5 (Germany, Fran ... Read More

    • Verdiperstat Emerging Drug Insight and Market Forecast – 2032

      Verdiperstat Emerging Drug Insight and Market Forecast – 2032 “Verdiperstat Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Verdiperstat for Amyotrophic Lateral Sclerosis in the 7MM. A detailed picture of the Verdiperstat for Amyotrophic Lateral Scleros ... Read More

    • Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast – 2032

      Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast – 2032 “Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Rexulti and Zoloft combination for Post-traumatic Stress Disorder in seven major markets. A ... Read More

    • LP-10 Emerging Drug Insight and Market Forecast – 2032

      LP-10 Emerging Drug Insight and Market Forecast – 2032 “LP-10 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LP-10 for Hemorrhagic Cystitis in the 7MM. A detailed picture of the LP-10 for Hemorrhagic Cystitis in the 7MM, i.e., United States, EU5 (Germa ... Read More

    • Tofersen Emerging Drug Insight and Market Forecast – 2032

      Tofersen Emerging Drug Insight and Market Forecast – 2032 “Tofersen Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Tofersen for Amyotrophic Lateral Sclerosis in the 7MM. A detailed picture of the Tofersen for Amyotrophic Lateral Sclerosis in the 7MM, i ... Read More

    • VAY736 Emerging Drug Insight and Market Forecast – 2032

      VAY736 Emerging Drug Insight and Market Forecast – 2032 “VAY736 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VAY736 for lupus nephritis in the seven major markets. A detailed picture of the VAY736 for lupus nephritis in the 7MM, i.e., United States, ... Read More

    • CR-845 Emerging Drug Insight and Market Forecast – 2032

      CR-845 Emerging Drug Insight and Market Forecast – 2032 “CR-845 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about CR-845 for Postoperative Pain in the 7MM. A detailed picture of the CR-845 for Postoperative Pain in the 7MM, i.e., United States, EU5 (Germa ... Read More

    • SUNOSI (Solariamfetol), Drug Insight and Market Forecast – 2032

      SUNOSI (Solariamfetol), Drug Insight and Market Forecast – 2032 “SUNOSI (Solariamfetol), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SUNOSI (Solariamfetol) for Excessive Daytime Sleepiness (EDS) in the 7MM. A detailed picture of the SUNOSI (Solariamfetol) fo ... Read More

    • Paltusotine Emerging Drug Insight and Market Forecast – 2032

      Paltusotine Emerging Drug Insight and Market Forecast – 2032 “Paltusotine Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about paltusotine for acromegaly in the seven major markets. A detailed picture of the paltusotine for acromegaly in the 7MM, i.e., Unite ... Read More

    • Gazyva Emerging Drug Insight and Market Forecast – 2032

      Gazyva Emerging Drug Insight and Market Forecast – 2032 “Gazyva Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Gazyva for lupus nephritis in the seven major markets. A detailed picture of the Gazyva for lupus nephritis in the 7MM, i.e., United States, ... Read More

    • STELARA (Ustekinumab), Drug Insight and Market Forecast – 2032

      STELARA (Ustekinumab), Drug Insight and Market Forecast – 2032 “STELARA (Ustekinumab), Drug Insight and Market Forecast – 2032” report provides comprehensive insights about STELARA (Ustekinumab) for Crohn’s disease (CD) in the 7MM. A detailed picture of the STELARA (Ustekinumab) for Crohn’s disease ... Read More

    • EPIDIOLEX Drug Insight and Market Forecast – 2032

      EPIDIOLEX Drug Insight and Market Forecast – 2032 “EPIDIOLEX Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EPIDIOLEX for Developmental and Epileptic Encephalopathy in the 7MM. A detailed picture of the EPIDIOLEX for Developmental and Epileptic Encephalopathy i ... Read More

    • ADP101 Emerging Drug Insight and Market Forecast – 2032

      ADP101 Emerging Drug Insight and Market Forecast – 2032 “ADP101 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ADP101 for Food Allergy in the 7MM. A detailed picture of the ADP101 for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, ... Read More

    • VE416 Emerging Drug Insight and Market Forecast – 2032

      VE416 Emerging Drug Insight and Market Forecast – 2032 “VE416 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VE416 for Food Allergy in the 7MM. A detailed picture of the VE416 for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, Ital ... Read More

    • Lorecivivint Emerging Drug Insight and Market Forecast – 2032

      Lorecivivint Emerging Drug Insight and Market Forecast – 2032 “Lorecivivint Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about lorecivivint for knee osteoarthritis (OA) in the seven major markets. A detailed picture of the lorecivivint for knee osteoarthri ... Read More

6 7 8 9 10 11 12 13 14 15

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings